Colorectal Neoplasms D015179

Related MeSH Hierarchy (6)

Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Intestinal Diseases » Colonic Diseases » Colorectal Neoplasms

Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Intestinal Diseases » Intestinal Neoplasms » Colorectal Neoplasms

Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Intestinal Diseases » Rectal Diseases » Colorectal Neoplasms

Description

Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.   MeSH

Hierarchy View

Subtype Terms (4)

Adenomatous Polyposis Coli
31 drugs (16 approved, 15 experimental)

Colonic Neoplasms
395 drugs (170 approved, 225 experimental)

Colorectal Neoplasms, Hereditary Nonpolyposis
20 drugs (16 approved, 4 experimental)

Rectal Neoplasms
204 drugs (100 approved, 104 experimental)


Phase 3 Indicated Drugs (143)

Phase 2 Indicated Drugs (421)

111in-imp-288

11d10

2-fluoropropionyl-labeled pegylated dimeric rgd peptide

3h1

68ganota-anti-her2 vhh1

68ga-rm2

90y-imp-288

9-ing-41

a166

ab680

ab928

abemaciclib (verzenio)

abituzumab

abt-751

abt-869

activated cik and cd3-muc1 bispecific antibody

ad5.f35-hgcc-padre

ad-cea vaccine

adecatumumab

afatinib (gilotrif)

ak104

ak-105

al2846

aldesleukin (proleukin)

aldoxorubicin

alectinib (alecensa)

allogeneic tumor cell vaccine

alpelisib (Piqray)

alpha-type-1-polarized dendritic cell

alt-803

alvac-cea-b7.1 vaccine

amifostine (ethyol)

anakinra (kineret)

andrographolide

antigen-loaded cultured dendritic cells

apatinib

aroplatin

artesunate

atorvastatin (lipitor)

atp128

autologous activated lymphocyte

autologous cd133+ stem cells

autologous dendritic cells

autologous lymphocytes

autologous tumor infiltrating lymphocytes

avapritinib (Ayvakit)

avelumab (bavencio)

axitinib (inlyta)

azacitidine (vidaza)

azd-4547

azd-5672

azd9150

bax69

becatecarin

betamethasone (celestone)

bey1107

bi 754091

bi 831266

bibh 1

bifidobacterium animalis

bintrafusp alfa

bleomycin (blenoxane)

bm7pe

bms-844203

bms-986016

bms-986340

bnc 105p

bo-112

bortezomib (velcade)

bosutinib (bosulif)

bryostatin

buparlisib

cabazitaxel (jevtana kit)

cabozantinib (cometriq)

calcium alumina-silicate

camrelizumab

canagliflozin (invokana)

cancer stem cell vaccine

cannabidiol (Epidiolex)

capmatinib

carcinoembryonic antigen peptide 1

cb-839

cea car-t cells

ceritinib (zykadia)

chidamide

chloroquinoxaline

ci-1040

cibisatamab

cik cells

cixutumumab

clobetasol (dermovate)

cm-24

compound 2055269

conatumumab

cpgj602

crizotinib (xalkori)

curcumin

cv301

cxd101

cy-503

cyclophosphamide (cytoxan)

d-1553

dabrafenib (tafinlar)

daratumumab (darzalex)

dasatinib (sprycel)

defactinib

dendritic cells

denosumab (prolia)

desmopressin (ddavp)

detoxpc

docetaxel (taxotere)

dostarlimab

dovitinib

duligotuzumab

durvalumab (imfinzi)

e 7070

e7820

eadm

efalex

efatutazone

eft508

egfr cart

elacytarabine

elu001

enadenotucirev

enmd 2076

ensituximab

entecavir (baraclude)

entinostat

entolimod

entrectinib (Rozlytrek)

enzastaurin

epacadostat

epothilone

eras-007

erythromycin (ilosone)

esg401

etbx-011

etbx-021

etbx-051

etbx-061

etirinotecan pegol (Onzeald)

etoposide (vepesid)

everolimus (zortress)

ezn-2208

falimarev

fam-trastuzumab deruxtecan-nxki (Enhertu)

ferumoxytol (feraheme)

figitumumab

fludarabine (fludara)

fludeoxyglucose f-18

fluoromisonidazole

fostamatinib

fpv-cv301

fuzheng yiliu

gadolinium

galunisertib

ganitumab

gastrin 17 vaccine

gb1275

gedatolisib

gemcitabine (gemzar)

gen1042

genistein

gi-4000

gi-6207

gi-6301

ginger

ginseng

gm102

gm-ct-01

gpc3 car-t cell

green tea

gsk-2636771

guadecitabine

gvax pancreatic cancer vaccine

hexyl 5-aminolevulinate (Cysview)

hlx208

hmbd-001

hydroxychloroquine (plaquenil)

ibi310

ibrutinib (imbruvica)

imatinib (gleevec)

imgatuzumab

immuncell-lc

imp288

inactivated influenza vaccine

inalimarev

incb001158

incomplete freund's adjuvant

indocyanine green (ic-green)

infigratinib

interferon gamma-1b (actimmune)

interleukin-12

isis 2503

isosulfan blue (lymphazurin)

ispinesib

ixabepilone (ixempra)

jab-21822

kpt-8602

lactobacillus rhamnosus

lamivudine (epivir)

lapatinib (tykerb)

larotrectinib (vitrakvi)

leac-102

lenalidomide (revlimid)

l-epigallocatechin

levocetirizine (xyzal)

linaclotide (linzess)

litronesib

lobaplatin

lomustine

Phase 1 Indicated Drugs (302)


Organization Involved with Phase 4 Indications (62)

Organization Involved with Phase 3 Indications (290)

1Globe Biomedical Co., Ltd.

AB Science

AEterna Zentaris

Aichi Medical University

AIG Hyderabad india

AIO-Studien-gGmbH

Alchemia Oncology

Allegheny Health Network

Alpha Scientific

American College of Radiology

American Rhinologic Society

Anhui College of Traditional Chinese Medicine

Anhui Medical University

Aptuit Inc.

Aragon Institute of Health Sciences

Arbeitsgemeinschaft fur Internistische Onkologie (AIO)

Arbeitsgruppe Lebermetastasen und Tumoren

Ardeypharm GmbH

Array BioPharma

AryoGen Pharmed Co.

Asian Institute of Gastroenterology

AstraZeneca

Auron Healthcare GmbH

Austin Health

Australasian Gastro-Intestinal Trials Group

Axcan

Beihua University

Biothera

Boehringer Ingelheim

Boston Biomedical

Bristol-Myers Squibb

Canadian Cancer Trials Group

Cancer and Leukemia Group B (CALGB)

Cancer Prevention Pharmaceuticals, Inc.

Cancer Research Campaign

Cancer Research UK

Capital Medical University

Catholic University of Sacred Heart, Rome

Catholic University of the Sacred Heart

Central South University

Centre Hospital Universitaire Hop Huriez

Changhai Hospital

China Academy of Chinese Medical Sciences

China Medical University

Chinese Academy of Medical Sciences

Chinese Medical University

Chongqing Medical University

Chonnam National University

CHU AMBROISE PARE

Chugai

CHU Henri Mondor

Cinnagen

City University of Hong Kong

Columbia University

Cornell University

Cosmo Pharmaceuticals

Daiichi Sankyo

D'Annunzio University of Chieti–Pescara

Deyang People's Hospital

Dutch Cancer Society

Dutch Colorectal Cancer Group

Dutch Health Care Insurance Board

Eastern Cooperative Oncology Group

Egyptian Foundation for Cancer Research

Eli Lilly

Epidemiological and Clinical Research Information Network

European Organisation for Research and Treatment of Cancer

Exystat

Federation Francophone de Cancerologie Digestive

First People's Hospital of Foshan

First People's Hospital of Hangzhou

Fondation ARCAD

Fondation Francaise de Cancerologie Digestive

Fondazione Giovanni Pascale

Fujian Medical University

G1 Therapeutics, Inc.

Gachon University

Gansu Provincial Hospital

Ghent University

Government of China

Government of Japan

Government of Singapore

Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)

Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente

Gruppo Oncologico Chirurgico Cooperativo Italiano

Gruppo Oncologico del Nord-Ovest

Gruppo Oncologico Italiano di Ricerca Clinica

Guangdong Provincial Hospital of Traditional Chinese Medicine

Guangxi Medical University

Guangzhou Medical University

Haixin Biotechnology Co. Ltd

Harvard University

Hebei University

Hefei University

Hellenic Oncology Research Group

Henan Medical University

Hengrui Therapeutics, Inc.

Hokkaido University

Hôpital Européen Georges-Pompidou

Hopital Paul Brousse

Hospital Avicenne

Hospital Clinico Lozano Blesa

Hospital Duran i Reynals

Hospital Universitario Ramon y Cajal

Huazhong University of Science and Technology

Immunicon

Immunovative Therapies

INDOX Cancer Research Network

Institut de Cancerologie de l'Ouest Paul Papin

Institut Gustave Roussy

Institut Hospitalier Franco-Britannique

IntegraGen SA

Isofol Medical AB

Istituto Nazionale per lo Studio e la Cura dei Tumori

Iwate Medical University

Japan Clinical Oncology Group

Japan Multinational Trial Organization

Jiangmen Central Hospital

Jilin University

J. W. Goethe University

Kantonsspital Aarau

Karolinska Institute

Katholieke Universiteit Leuven

Klinikum Oldenburg

Koningin Wilhelmina Fonds

Korea University

Leiden University

Light Sciences Oncology

Linkoping University

Ludwig Maximilians University

Lund University

Mast Therapeutics

Mayo Clinic

Medical Research Council

Meizhou City Hospital Of Guangdong Provience

Melbourne Health

Merck KGaA

Mologen AG

Moorgreen Hospital, Southampton

Multicenter Clinical Study Group of Osaka

Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group

Nanchang University

NanKai University

Nantong University

National Cancer Center, Japan

National Cancer Center, Korea

National Cancer Institute, France

National Cancer Institute (NCI)

National Cancer Institute of Thailand

National Health and Medical Research Council, Australia

National Heart, Lung, and Blood Institute (NHLBI)

National Hospital Organization Kyoto Medical Center

National Institutes of Health (NIH)

National University of Singapore

Netherlands Cancer Institute

Nordic Pharma Group

North Central Cancer Treatment Group

Northern California Cancer Center

Northwell Health

Novartis

NRG Oncology

NSABP Foundation

Oncológica

Onkologische Schwerpunktpraxis Eppendorf

Ono Pharmaceuticals

OptiNose AS

Orebro University

Osaka University

Pari Pharma GmbH

Peking University

People's Hospital of Leshan

People's Liberation Army of China

Pierre and Marie Curie University

Pierre Fabre

PledPharma AB

Presidio Ospedaliero di Livorno

Prologue Research International

Qidong Gaitianli Medicines Co., Ltd

Qilu Pharmaceutical Co., Ltd.

Quercegen Pharmaceuticals

Radboud University

Regeneron

Region Syddanmark

Rocky Mountain Cancer Centers

Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust

Royal Marsden Hospital NHS Trust

Sanofi-Synthelabo

SCRI Development Innovations

Second Military Medical University

Seoul National University

Servier

Shandong Provincal Cancer Hospital

Shanghai Biomabs Pharmaceuticals Co Ltd

Shanghai Henlius Biotech

Shanghai Zhangjiang Biotechnology Limited Company

Shantou University

Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.

Sichuan University

Simcere Pharmaceutical Co., Ltd

Sirtex Medical

Sky Ridge Medical Center

SLA Pharma

Solasia Pharma K.K.

Soochow University

Soonchunhyang University

Southern Italy Cooperative Oncology Group

Southern Medical University

Southwest Medical University

Southwest Oncology Group

Spanish Cooperative Group for Gastrointestinal Tumour Therapy

Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

Stand Up To Cancer

Stanford University

State Key Laboratory of Cancer Biology

St. Claraspital Basel

Sugen

Sungkyunkwan University

Sun Yat-Sen University

Surgimab

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Swiss Group for Clinical Cancer Research

Symphogen A/S

Taizhou Mabtech Pharmaceutical Co., Ltd.

Takeda

The First People's Hospital of Changzhou

The Nordic Colorectal Cancer Biomodulation Group

The Swedish Research Council

Tianjin Medical University

Tianjin University

Tokyo Medical and Dental University

Tokyo Medical University

Translational Research Informatics Center, Kobe, Hyogo, Japan

Tsinghua University

UNICANCER

United States Army

Universidad Autonoma de Barcelona

Universidad de Cordoba

Universitaetsklinikum Schleswig-Holstein

University of Antwerp

University of Arizona

University of Birmingham

University of Bologna

University of Burgundy

University of California, Irvine

University of California, Los Angeles

University of California, San Francisco

University of Cambridge

University of Crete

University of Florence

University of Freiburg

University of Hamburg

University of Hohenheim

University of Leeds

University of Lille

University of Michigan

University of Milan

University of Montpellier

University of Nice Sophia Antipolis

University of North Carolina at Chapel Hill

University of Ottawa

University of Oxford

University of Paris

University of Pennsylvania

University of Perugia

University of Pisa

University of Rochester

University of Rostock

University of Sherbrooke

University of Southern California

University of Southern Denmark

University of St-Luc

University of Sydney

University of Texas at Houston

University of Toronto

University of Ulsan

Uppsala University

US Oncology

Utrecht University

Vanderbilt University

Velindre NHS Trust

Wuhan University

XBiotech, Inc.

Xiamen University

Xuzhou Medical University

Yale University

Yeshiva University

Yeungnam University

Yonsei University

ZKES GmbH

ZonMw: The Netherlands Organisation for Health Research and Development

Organization Involved with Phase 2 Indications (500)

4SC AG

Aadi, LLC

Aalborg University

Aarhus University

AbbVie

Academic and Community Cancer Research United

Actuate Therapeutics Inc.

Agendia

Aix-University of Marseille

Aju Pharm

Albany Medical College

Allakos, Inc.

Altor Bioscience

Alza

Amal Therapeutics

American Cancer Society, Inc.

Ananda Hemp, Inc.

Apices Soluciones S.L.

Aptium Oncology

Aqualis

Arbeitsgemeinschaft medikamentoese Tumortherapie

Arca Biopharma, Inc.

Aronex Pharmaceuticals

Assign Clinical Research GmbH

Assistance Publique - Hôpitaux de Paris

Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socials

Association pour la Recherche sur le Temps Biologique et la Chronothérapie

Astex Pharmaceuticals, Inc.

Austrian Breast and Colorectal Cancer Group

Austrian Society Of Surgical Oncology

AVEO Pharmaceuticals

Azienda Ospedaliera Antonio Cardarelli

Azienda Ospedaliera G. Rummo

Azienda Sanitaria Rummo, Benevento, Division of Medical Oncology

Badalona Hospital Germans Trias i Pujol

Ballarat Health Services

Barretos Cancer Hospital

Barts & The London NHS Trust

Bavarian Nordic

Baxalta

Beijing Gene Plus Technology

Beijing Genova Biotech Company, Ltd.

Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.

Binex

Biocompatibles International plc

Biogen

BioLab 612 LLC

Biontech

Biostar

Biotech Pharmaceutical Co., Ltd.

British Columbia Cancer Agency

Brown University

Calithera Biosciences

CancerCare Manitoba

Cancer Insight, LLC

Cancer League of Colorado, Inc

Cancer Treatment Centers of America

Cantonal Hospital of St. Gallen

Cardiff Oncology

Cardiff University

Cascadian Therapeutics Inc.

Case Western Reserve University

Catalan Institute of Health

Catalysis SL

Cato Research

Celator Pharmaceuticals

Celgene

Celleron Therapeutics Ltd.

Center for Molecular Medicine

Centocor

Central European Cooperative Oncology Group

Central European Society for Anticancer Drug Research (CESAR)

Centre Georges Francois Leclerc

Centre Hospitalier Cholet

Centre Hospitalier de Belfort-Montbelliard

Centre hospitalier du Mans

Centre Hospitalier du Mittan-MONTBELIARD

Centre Hospitalier La Source, Orleans

Centre hospitalier Purpan

Centre Jean Bernard

Centre Jean Perrin

Centre Leon Berard

Centre Paul Strauss

Centre Val d'Aurelle

Chang Gung University

Chao Family Comprehensive Cancer Center

Chinese University of Hong Kong

Chiron

Chong Kun Dang Pharmaceutical

Chongqing Precision Biotech Co., Ltd

CHU Besançon

CHU Charleroi

City of Hope National Medical Center

City University of New York

Cleveland BioLabs

ClinAssess GmbH

Clinica Universidad de Navarra

Concerto HealthAI

Consorci Sanitari de Terrassa

Criterium, Inc.

CSSS Alphonse-Desjardins

CSSS Champlain - Charles-Lemoyne Hospital

CTI BioPharma

Curie Institute

Cytavis Biopharma GmbH

Cyto Pulse Sciences, Inc.

Daehang Hospital

Dalian Medical University

Danish Cancer Society

Desert Regional Comprehensive Cancer Center

Developmental Therapeutics Consortium

Dokuz Eylul University

Doris Duke Charitable Foundation

DSM

Duke University

ECOG-ACRIN Cancer Research Group

Effector Therapeutics

Eisai

Emek Medical Center

Emory University

Emtora Biosciences

Enzon

EpicentRx, Inc.

EPS Corporation

Esslingen University

Eudax S.r.l.

Evelo Biosciences

Exelixis

Federal State Institution of Health of the Yaroslav Region Regional Clinical Oncology Hospital

FeRx

Fondazione del Piemonte per l'Oncologia

Fondazione GONO

Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milano

Forty Seven, Inc.

François Rabelais University

Free University of Brussels

Friedrich Schiller University

Fundacion CRIS de Investigación para Vencer el Cáncer

Galectin Therapeutics Inc.

Galmed Pharmaceuticals Ltd

GamaMabs Pharma

Garden State Cancer Center

Generic Devices Consulting, Inc.

Genmab

Genzyme

Georgetown University

George Washington University

Geriatric Oncology Consortium

Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH

Gilead Sciences

GISCAD Foundation

Glaxo Wellcome

Goshen Health System

Government of Norway

Government of Russia

Government of Spain

Government of Taiwan

Gradalis, Inc.

Grande Ospedale Metropolitano Niguarda - Milano

Green Cross Corporation

Groupe hospitalier St Joseph-PARIS

Grupo de Investigacao do Cancro Digestivo

Grupo Espanol Multidisciplinario del Cancer Digestivo

Grupo Hospital de Madrid

Grupo Oncologico Cooperativo del Sur

Guangzhou University

Hallym University

Harbin Medical University

Hebrew University

Hellenic Cooperative Oncology Group

Hemispherx Biopharma

Herbert Irving Comprehensive Cancer Center

Highlight Therapeutics

Hiroshima Prefectural Hospital

Hoosier Cancer Research Network

Hopital Rene Huguenin_Intitut Curie_Paris

Hospital A.C. Camargo

Hospital Clinico de Santiago, Spain

Hospital de Denia

Hospital de Fuenlabrada de Madrid

Hospital de Sant Pau i Santa Tecla de Tarragona

Hospital General de Manresa

Hospital General Universitario de Castellón

Hospital general Universitario de Ciudad Real

Hospital General Universitario Gregorio Marañon

Hospital General Yague

Hospital of Southern Norway Trust

Hospital Son Llatzer

Hospital Universitario Arnau de Vilanova de Lleida

Hospital Universitario de Fuenlabrada

Hospital Universitario Puerta del Mar

Hospital Universitari Son Dureta

Hospital Xeral Cies de Vigo

Hosptial Morales Meseguer

Humanitas University

Hyogo Medical University

Icahn School of Medicine at Mount Sinai

Idorsia Pharmaceuticals Ltd.

IFOM

Ignyta, Inc.

immatics Biotechnologies GmbH

Immodulon Therapeutics Ltd

Immunomedics

Imperial College London

INCLIVA

Incyte

Indiana University

InnoPharma

Innovent Biologics (Suzhou) Co. Ltd.

Inova Health System

Institut Bergonié

Instituto de Investigación Sanitaria Aragón

Instituto do Cancer do Estado de São Paulo

Institut Paoli-Calmettes

Institut Sainte Catherine

InterMune

International Drug Development Institute

Inveresk Research

Ioannina University Hospital

iOMEDICO AG

Iovance

Ipsen

IQVIA

Istituti Fisioterapici Ospitalieri

Istituti Ospitalieri di Cremona

Istituto Clinico Humanitas - Rozzano (MI), Italy

Istituto Nazionale dei Tumori di Napoli - IRCCS - Fondazione G. Pascale

Janssen Pharmaceutica NV

Japan Clinical Cancer Research Organization

Jeil Pharmaceutical Co., Ltd.

Jennerex Inc.

Jiangsu Cancer Institute & Hospital

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Jilin Provincial Tumor Hospital

Jinan University

Jingzhou Central Hospital

Johns Hopkins University

John Wayne Cancer Institute

Kadmon

Kanazawa University

Kansai Rosai Hospital

Kantonsspital Graubünden

Karl Storz

Karyopharm Therapeutics Inc

King Abdul-Aziz University

Kitano Hospital

Kumamoto University

Kyowa Hakko Kirin

Kyushu University

LabCorp

Laboratorio Elea S.A.C.I.F. y A.

LanZhou University

Leaders In Oncology Care, Harley St, London

Lille Catholic University

London Regional Cancer Center

Lotte & John Hecht Memorial Foundation

LSK BioPartners Inc.

Luzerner Kantonsspital

Maastricht University

MacroGenics

Main Line Health

Mario Negri Institute

Martin Luther University

Mary Crowley Cancer Center

Medac

Medical College of Wisconsin

Medical University Innsbruck

Medical University of Vienna

MediGene

MedImmune

Medivation

Memorial Sloan-Kettering Cancer Center

Menarini Group

Merck Serono

Merrimack Pharmaceuticals

Microbio Co Ltd

Miguel Hernández University

Millennium Pharmaceuticals

Mirror Pharms

MolMed S.p.A.

Morphotek

Nanjing University

NantCell, Inc.

NantWorks

National Cancer Center Hospital East

National Cancer Institute, Egypt

National Cancer Institute, Italy

National Cheng Kung University

National Comprehensive Cancer Network

Nationales Centrum fur Tumorerkrankungen

National Hospital Organisation Shikoku Cancer Centre

National Hospital Organization Osaka National Hospital

National OncoVenture

National Taiwan University

Nektar Therapeutics

NewBiotics

New York University

NKMAX Co., Ltd.

Northeast Ohio Medical University

Northwestern University

Norwegian Cancer Society

Norwegian University of Science and Technology

Noxxon AG

Ohio State University

Olivia Newton-John Cancer Research Institute

Oncoceutics, Inc.

Oncolytics Biotech

Ontario Cancer Research Network

Onyvax

Oregon Health and Science University

Oryx GmbH & Co. KG

Osaka Medical College

OSI Pharmaceuticals

Oslo Metropolitan University

Ottawa Regional Cancer Foundation

Oxford BioMedica

People's Hospital of Zhongshan

PersonGen BioTherapeutics (Suzhou) Co., Ltd.

Peter MacCallum Cancer Centre

PharmaBio Development Inc.

Pharmacia

Pharma Consulting Group AB

PharmaMar

Philogen S.p.A.

Photocure

PhytoCeutica

Pivotal S.L.

Plexxikon

Polo Oncologico Area Vasta Nord Ovest

Poniard Pharmaceuticals

PPD

Precision Biologics, Inc

Prism Research

PsiOxus Therapeutics Ltd

PTEN Research Foundation

Puma Biotechnology, Inc.

PureTech

Qingdao Zhixin Health Technology Co., Ltd.

Quebec Clinical Research Organization in Cancer

Queen's University, Belfast

Radiation Oncology Center of Olathe

Radiation Therapy Oncology Group

Regione Lombardia

Rhode Island Hospital

Rovira i Virgili University

Rutgers University

Saint-Joseph University

San Carlos University Hospital, Madrid

Scandion Oncology A/S

Seattle Genetics

Second People's Hospital of Yibin

Shanghai Junshi Bioscience Co.,Ltd.

Shanxi Medical University

Shengjing Hospital

Shenzhen Hank Bioengineering Institute

Shenzhen Hornetcorn Bio-technology Company, LTD

Shenzhen University

Sinocelltech Ltd.

SOFAR S.p.A.

Sorbonne University

Southwestern Regional Medical Center

Sponsor GmbH

STABIL - Statistische und Biometrische Lösungen

State University of New York, Buffalo

St. Jude Children's Hospital

St. Marianna University School of Medicine

Stony Brook University

Sumitomo Dainippon

Sunshine Lake Pharma Co., Ltd.

Swedish Cancer Institute

Swedish Institute for Infectious Disease Control

Symphony Capital

Syndax Pharmaceuticals

Syntrix Biosystems, Inc.

Taiwan Leader Biotech Corp.

Technical University of Dresden

Technion University

Teclison Ltd.

Temple University

Tesaro

TFS Trial Form Support

The Beatson West of Scotland Cancer Centre

The Beijing Pregene Science and Technology Company, Ltd.

The Catholic Medical Center

The Christie NHS Foundation Trust

The First People's Hospital of Jingzhou

The Jewish General Hospital, Montreal QC, Canada

Theradex

The Rogosin Institute

The Scientific and Technological Research Council of Turkey

The University of Hong Kong

The University of Texas, Dallas

Thomas Jefferson University

Tohoku University

Transgene

Translational Drug Development

Translational Oncology Research International

Treos Bio

Trium Analysis Online GmbH

Tsukuba University

TTY Biopharm

Tufts University

Unidad Integral de Investigación en Oncología S.L.

Union Therapeutics

Universidad Autonoma de Madrid

Universidad Carlos III Madrid

Universidad Complutense de Madrid

Universitat de Vic

Universität Duisburg-Essen

Université catholique de Louvain

University Hospital, Rijeka

University of Adelaide

University of Alabama, Birmingham

University of Alberta

University of Athens

University of Bergen

University of Bern

University of Bordeaux

University of Brescia

University of British Columbia

University of Calgary

University of California, Davis

University of California, San Diego

University of Campania Luigi Vanvitelli

University of Campinas

University of Chicago

University of Cincinnati

University of Cologne

University of Colorado, Denver

University of Copenhagen

University of Duesseldorf

University of Duisburg-Essen

University of Edinburgh

University of Florida

University of Franche-Comté

University of Geneva

University of Genoa

University of Grenoble

University of Groningen

University of Heidelberg

University of Illinois

University of Illinois at Chicago

University of Ioannina

University of Iowa

University of Kansas

University of Kentucky

University of Las Palmas de Gran Canaria

University of Lausanne

University of Leicester

University of Lorraine

University of Mannheim

University of Medicine and Dentistry of New Jersey

University of Medicine and Pharmacy Cluj-Napoca, Romania

University of Miami

University of Nantes

University of Nebraska

University of Oslo

University of Pittsburgh

University of Poitiers

University of Regensburg

University of Reims

University of Santiago

University of Saskatchewan

University of Shizuoka

University of South Carolina

University of South Florida

University of Texas, San Antonio

University of the Philippines

University of Tokyo

University of Toulouse

University of Tuebingen

University of Turin

University of Ulm

University of Utah

University of Valencia

University of Versailles

University of Vienna

University of Washington

University of Wisconsin

University of Zaragoza

University of Zurich

Val d'Aurelle Cancer Institute

Vastra Gotaland Region

Vedanta Biosciences, Inc.

Veeda Clinical Research

Verlyx Pharma Inc

Vietnamese Military

Virginia Mason Medical Center

ViroStatics srl

Vita-Salute University of Milano. Italy

Wake Forest University

Washington University in St. Louis

Wayne State University

Western General Hospital, Australia

Western Hospital, Footscray, Victoria. Australia

Wyeth

Yakult Honsha Co., LTD

YM Biosciences

Yooyoung Pharmaceutical Co.,Ltd.

Yuhan Pharmaceutical Company

Organization Involved with Phase 1 Indications (84)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.